share_log

海思科:关于利鲁唑口溶膜EXSERVAN项目许可引进终止并计提减值准备的公告

Haisco Pharmaceutical Group: Announcement on licensing and termination of the riluzole oral solution EXSERVAN project and preparation for impairment

Sensex a share ·  Apr 29
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more